Archives

To view past issues of The GIST and Sarcoma Journal, click the cover image.

 

The GIST and  Sarcoma Journal, Volume 3, Number 4

Journal Club and Sarcoma-Related News

The Fifth Pillar of Cancer Treatment: Is It Time to Explore Immunotherapy for GIST?

Highlights from a Year With Significant Advances in Treating Sarcoma and New Findings on GIST

_______________________________

The GIST and  Sarcoma Journal, Volume 3, Number 3

Journal Club and Sarcoma-Related News

The Trabectedin Story: How a New Combination Is Shifting the Paradigm of Treatment

Novel Combination—Olaratumab + Doxorubicin— Suggests Potential Paradigm Shift in Treatment of Soft-Tissue Sarcoma

ESMO 2016 Highlights: Selected Abstracts in GIST, Sarcomas

_______________________________

archives_v3n1The GIST Cancer Journal, Volume 3, Number 2

Journal Club and Sarcoma-Related News

The GIST Cancer Journal Interview Checkpoint Inhibitors and Sarcomas: ASCO Offers Insights Into What to Expect and Why There Is Optimism

Hereditary Gastrointestinal Stromal Tumor (GIST): A Growing Awareness of Mutational Subtypes Is Redefining Recommendations for Familial Screening, Surveillance

_______________________________


archives_v3n1
The GIST Cancer Journal, Volume 3, Number 1

Journal Club and Sarcoma-Related News

Imaging strategies to detect recurrent GIST after surgery

ESMO Report: Recapping pivotal issues in management
of GIST

_______________________________


v2n1_cover_archive
The GIST Cancer Journal, Volume 2, Number 4

Case Report: A Patient with a High-Risk Resected Gastric GIST Tumor and a PDGFRA D842V Mutation

2015 CTOS Meeting Highlights:  CTOS Sessions Redefine Combination Therapies, Sequential Management Strategies in GIST and Related Sarcomas

The GIST Cancer Journal Interview  Exploring the Enormous Potential of Immunotherapy in GIST and Its Microenvironment

_______________________________


v2n1_cover_archive
The GIST Cancer Journal, Volume 2, Number 3

Identifying Drug Sensitivities With Mutational Analysis to Optimize Treatment

The Gastroenterologist and GIST: Becoming More of a Diagnostician’ In the Continuum of Care

Case Report: Resection of Large GIST After Neoadjuvant Therapy

_______________________________


v2n1_cover_archive
The GIST Cancer Journal, Volume 2, Number 2

Population-Based Study Provides Insight Into GIST Epidemiology, Risk of Additional Cancers

Tracking the Trials and Progress of Drugs in the Pipeline: New Directions, Novel Treatments

ASCO Highlights: Selected Abstracts Focus on Strategies to Circumvent TKI Resistance

_______________________________

v2n1_cover_archiveThe GIST Cancer Journal, Volume 2, Number 1

New Targets, Novel Treatments Could Achieve Translational Results and Enhanced Apoptosis of GIST Cells

Surgical Management, Clinical Outcomes in Rare GIST: Emerging Data Highlight Conservative Strategies, Preoperative TKI Use

_______________________________

cover_v1n4The GIST Cancer Journal, Volume 1, Number 4

Immunotherapy Drives a Paradigm Shift Toward a New Model of Treatment

Reassessing Risk and Prognostic Factors in GIST:  Updated Histology Codes Redefine Epidemiology of the Disease

Interview: GIST Investigator Highlights Key Trends in Epidemiology of the Disease

Managing Side Effects of TKI Treatment: Duration of Therapy in the Face of Toxicity

Interview: Special Considerations to Minimize the Impact of Side Effects

_______________________________

v1n3_coverThe GIST Cancer Journal, Volume 1, Number 3

Building a New Paradigm in CombinationTherapy: Trends, Targets, and Pivotal Trials

High Index of Suspicion for Side Effects of Imatinib Maintains Adequate Dosing, Consistent Compliance

The LRG-NIH Virtual GIST Tumor Board Goes Global

Revisiting ASCO 2014: Potential Translational Impact

 _______________________________

cover_v1n2The GIST Cancer Journal, Volume 1, Number 2

Clinical Imperatives in GIST: Impact of Molecular Subtypes on Resistance to Therapy

Surgery in Metastatic GIST in the TKI Era: Crucial Decisions to Optimize Outcomes

Current Concepts, New Perspectives on the Genetic Basis of GISTs Lacking KIT and PDGFRA Mutations

Nurse’s Corner: Clinical Trial Education Helps Patients Overcome Barriers to Enrollment

Life Raft Group Establishes First Pediatric GIST Virtual Tumor Board in Partnership with NIH

 _______________________________

cover_v1n1

The GIST Cancer Journal, Volume 1, Number 1

Current Clinical Trials for Metastatic GIST: Updating the Treatment Paradigm

Risk of Recurrence of Primary GIST: Available Tools Compared and Contrasted

CTOS Meeting Highlights: Emerging Concepts With Potential Impact

Posters from CTOS: What’s Hot in Biomarkers and New Treatment